Analysts at StockStory recommend avoiding AXIS Capital, citing three key concerns. The company's revenue grew at a mediocre 6.8% compounded annual rate over the last five years, below the firm's standard for the insurance sector. Net premiums earned expanded at just 5.9% annually over the same period, signaling soft demand. While earnings per share rose 14.5% annually over the past two years, that growth was deemed unimpressive. The stock trades at 1.3 times forward price-to-book, or $113.36 per share, a valuation the analysts consider fair but not compelling enough to warrant a buy.
AXIS Capital Holdings LtdNet premiums earned expanded at just 5.9% annually over five years, signaling soft demand.